Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 396 results for "zydus group"

Torrent Group & Cadila Healthcare among top political donors from Gujarat during 2013-14
Indian Express

Zydus, Torrent among top donors to Cong, NCP in 2014 elections

Corporate majors like Cadila Healthcare Ltd and Torrent Group were among the top donors from Gujarat to have contributed to the election kitty of Indian National Congress (INC) and Nationalist Congress Party (NCP) for the 2014 Lok Sabha elections. ... Hindu Business Line, 1 month ago

Zydus begins Phase - III study of Saroglitazar in NASH, a liver disease caused by obesity, diabetes and lipid disorders

Details Category: Small Molecules Published on Sunday, 11 January 2015 21:06 Hits: 45 January 9, 2015 I The Zydus group announced the initiation of Phase III clinical trials to study its effect in adult nonalcoholic steatohepatitis (NASH) ...
 PipelineReview2 weeks ago

Buy Cadila Healthcare; target of Rs 1715: Firstcall

Firstcall Research report on Cadila Healthcare "For the Second quarter ended Sept 30, 2014, Zydus Cadila reported sales of Rs. 21080.00 mn, up by 20.68% from Rs. 17467.90 mn in the corresponding quarter of the previous year on a consolidated ...
 Moneycontrol.com1 month ago Cadila launches first cheaper version of a multi-billion dollar drug  VC Circle1 month ago Cadila Healthcare Q2 net up 52% at Rs 278 crore  The Financial Chronicle2 months ago

Top corporate news of the day - December 10, 2014

Reliance Industries Ltd (RIL) India and China's Shandong Ruyi Science and Technology Group Co Ltd — the latter through its wholly owned subsidiary — have executed definitive agreements for a joint venture in textiles. (BS) New Zealand awarded ...
 India Infoline1 month ago
Financial Express

STARCH : Indian diabetes population consumes high amounts of carbohydrates

Bayer Zydus Pharma, in collaboration with Prof Dr. Shashank Joshi (Padma Shri awardee and President of Association of Physicians of India) and nine other imminent endocrinologists/diabetologists, conducted the STARCH study across five regions in ...
 India Infoline2 months ago Indian diabetics consume high amount of carbohydrates: Study  ZeeNews.com2 months ago
[x]  

Zydus Cadila Launches Adalimumab Biosimilar in India

Zydus Cadila is the first company to launch a biosimilar of Amgen's Adalimumab, a top selling therapy for rheumatoid arthritis and other autoimmune disorders. The biosimilar has been approved by the Drug Controller General of India and will be ...
 Contract Pharma1 month ago Zydus lance le premier biosimilaire dadalimumab au monde  Gnom.es1 month ago Zydus Cadila becomes world's first company to launch biosimilar of Adalimumab  News-Medical.Net1 month ago Zydus Launches World's First Biosimilar of Adalimumab  BioSpace1 month ago
[x]  

Supernus Files Trokendi XR Patent Infringement Lawsuit - Analyst Blog

Supernus Pharmaceuticals, Inc. ( SUPN ) has filed a patent infringement lawsuit against Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited accusing them of infringement of three patents covering Supernus' antiepileptic drug, Trokendi XR.
 Nasdaq2 months ago Supernus Sues Zydus for Infringement of Trokendi XR(R) Patents  Stockwatch2 months ago Supernus Pharmaceuticals Sues Zydus Pharmaceuticals (USA) Inc. For Infringement Of Trokendi XR(R) Patents  BioSpace2 months ago Supernus Pharmaceuticals : Sues Zydus for Infringement of Trokendi XR(R) Patents  4 Traders2 months ago
[x]  

Zydus site clears data integrity hurdle in FDA audit?

GMT 2015 Informa plc. All rights reserved. This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT ...
 Scrip2 weeks ago

Torrent Pharmaceuticals : Pharma inks pact with Reliance for 3 biosimilars

Ahmedabad: City-based Torrent Pharmaceuticals , a part of the Sudhir Mehta -led Torrent group, has entered into an exclusive licensing agreement with Reliance Life Sciences for marketing three biosimilars - Rituximab, Adalimumab and Cetuximab - in ...
 4 Traders4 weeks ago Torrent Pharma inks pact with Reliance for 3 biosimilars [DNA : Daily News & Analysis (India)]  Pharmacy Choice4 weeks ago

Zydus's ''fingerprint match'' Humira version debuts in India

GMT 2014 Informa plc. All rights reserved. This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT ...
 Scrip1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less